February 13, 2013
1 min read
Save

Victus femtosecond laser platform cleared for arcuate incisions

The Victus femtosecond laser platform has received 510(k) clearance from the U.S. Food and Drug Administration for the creation of penetrating arcuate incisions, according to a news release from Bausch + Lomb Technolas.

The clearance covers use of the device to create penetrating arcuate incisions in the cornea for patients undergoing cataract surgery or other ophthalmic treatment in which such an incision is required.

The Victus platform received the CE mark in Europe in 2011 and FDA clearance in the U.S. in July 2012.

In the U.S., the system was previously approved to create corneal flaps during LASIK and anterior capsulotomy during cataract surgery. It has the same approvals in Europe as in the U.S., along with IntraCor, capsulotomy and lens fragmentation.